Literature DB >> 3986540

Chemical activation of the mesencephalic locomotor region.

E Garcia-Rill, R D Skinner, J A Fitzgerald.   

Abstract

Electrical stimulation of the mesencephalic locomotor region (MLR) in the precollicular-postmammillary transected cat is known to induce controlled locomotion on a treadmill. We have been able to induce and block locomotion in this preparation by using localized infusions of transmitters and their agonists and antagonists. Infusions of the GABA antagonists bicuculline and picrotoxin into the MLR elicit locomotion at low concentration (5 mM). Applications of muscimol (5 mM) or GABA (0.5 M) were found to block chemically-induced locomotion, as well as electrically-elicited and spontaneous walking. Priming infusions of Diazepam amplified the blockage of locomotion by GABA. On the other hand, applications of strychnine (10 mM) were ineffective in inducing stepping, as were infusions of the excitatory agents glutamic acid, acetylcholine and norepinephrine. These findings suggest that the MLR is under inhibitory GABAergic input. The substantia nigra is the only known afferent to the MLR located posterior to the brainstem transection, and is a likely source for this input. A model is proposed to account for our results, as well as those of others, and it provides a working hypothesis for the neurochemical events occurring in brainstem centers which modulate locomotor events.

Entities:  

Mesh:

Substances:

Year:  1985        PMID: 3986540     DOI: 10.1016/0006-8993(85)90006-x

Source DB:  PubMed          Journal:  Brain Res        ISSN: 0006-8993            Impact factor:   3.252


  30 in total

1.  Inhibition of midbrain-evoked tonic and rhythmic motor activity by cutaneous stimulation in decerebrate cats.

Authors:  C A Beyaert; P Haouzi; F Marchal
Journal:  Exp Brain Res       Date:  2003-01-31       Impact factor: 1.972

2.  Commentary: the pedunculopontine nucleus: clinical experience, basic questions and future directions.

Authors:  P Mazzone; E Scarnati; E Garcia-Rill
Journal:  J Neural Transm (Vienna)       Date:  2010-12-25       Impact factor: 3.575

3.  Lhx3-Chx10 reticulospinal neurons in locomotor circuits.

Authors:  Frédéric Bretzner; Robert M Brownstone
Journal:  J Neurosci       Date:  2013-09-11       Impact factor: 6.167

4.  The cellular and fiber organization of the locomotor areas of the brain stem of the cat.

Authors:  T G Kebkalo; V K Berezovskii
Journal:  Neurosci Behav Physiol       Date:  1993 May-Jun

5.  A spinal GABAergic mechanism is necessary for bladder inhibition by pudendal afferent stimulation.

Authors:  Meredith J McGee; Zachary C Danziger; Jeremy A Bamford; Warren M Grill
Journal:  Am J Physiol Renal Physiol       Date:  2014-08-20

6.  Complete spinal cord transection at different postnatal ages: recovery of motor coordination correlated with spinal cord catecholamines.

Authors:  J W Commissiong; G Toffano
Journal:  Exp Brain Res       Date:  1989       Impact factor: 1.972

Review 7.  The pedunculopontine tegmental nucleus: implications for a role in modulating spinal cord motoneuron excitability.

Authors:  Eugenio Scarnati; Tiziana Florio; Annamaria Capozzo; Giuseppina Confalone; Paolo Mazzone
Journal:  J Neural Transm (Vienna)       Date:  2010-12-16       Impact factor: 3.575

8.  Morphological and electrophysiological properties of serotonin neurons with NMDA modulation in the mesencephalic locomotor region of neonatal ePet-EYFP mice.

Authors:  Renkai Ge; Ke Chen; Yi Cheng; Yue Dai
Journal:  Exp Brain Res       Date:  2019-11-12       Impact factor: 1.972

9.  Muscimol microinfused into the nigrotegmental target area blocks selected components of behavior elicited by amphetamine or cocaine.

Authors:  S E Bachus; K Gale
Journal:  Naunyn Schmiedebergs Arch Pharmacol       Date:  1986-06       Impact factor: 3.000

10.  Avian locomotion activated by brainstem infusion of neurotransmitter agonists and antagonists. II. gamma-Aminobutyric acid.

Authors:  G N Sholomenko; G D Funk; J D Steeves
Journal:  Exp Brain Res       Date:  1991       Impact factor: 1.972

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.